GlassScriptPhysician profile
Patrick F Annello
NPI 1508066259
$20,126.43
in general payments reported to CMS, 2019-2025
56 companies · $8,733 in 2025
The $8,733 reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $1,193 · 2021: $2,203 · 2022: $1,840 · 2023: $2,543 · 2024: $2,224 · 2025: $8,733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,119 · Consulting Fee: $5,183 · Travel and Lodging: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,119.11 |
| Consulting Fee | $5,183.00 |
| Travel and Lodging | $1,198.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $6,962.05 | 2024-2025 | |
| Abbvie INC. | $2,171.56 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Abbott Laboratories | $1,529.23 | 2019-2024 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $1,371.91 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $823.41 | 2022-2025 | Belbuca, Xtampza, Nucynta |
| Pfizer INC. | $559.98 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $507.70 | 2019-2023 | Relistor |
| Allergan, INC. | $427.33 | 2019-2022 | |
| Vertos Medical, INC. | $425.08 | 2019-2023 | Mild Device Kit |
| Nevro Corp. | $403.47 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $297.85 | 2020-2021 | |
| Forte Bio-Pharma LLC | $293.31 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Azurity Pharmaceuticals, INC. | $287.10 | 2023-2025 | Horizant, Horizant |
| Medtronic, INC. | $275.50 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Valinor Pharma, LLC | $274.99 | 2023-2025 | Movantik |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Annello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.